| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Achieving effective informed oversight by DMCs in COVID clinical trials
|
DeMets, David L.
|
|
|
126 |
C |
p. 167-171
|
artikel
|
| 2 |
A systematic review highlights the need to improve the quality and applicability of trials of physical therapy interventions for low back pain
|
Cashin, Aidan G.
|
|
|
126 |
C |
p. 106-115
|
artikel
|
| 3 |
Corrigendum to Rounding, but not randomization method, non-normality, or correlation, affected baseline P-value distributions in randomized trials. J Clin Epidemiol 2019;110:50-62
|
Bolland, M.J.
|
|
|
126 |
C |
p. 226
|
artikel
|
| 4 |
Editorial Board
|
|
|
|
126 |
C |
p. IFC
|
artikel
|
| 5 |
Evidence-based medicine in times of crisis
|
Djulbegovic, Benjamin
|
|
|
126 |
C |
p. 164-166
|
artikel
|
| 6 |
External validation demonstrated the Ottawa SAH prediction models can identify pSAH using health administrative data
|
English, Shane W.
|
|
|
126 |
C |
p. 122-130
|
artikel
|
| 7 |
Female under-representation in sepsis studies: a bibliometric analysis of systematic reviews and guidelines
|
Antequera, Alba
|
|
|
126 |
C |
p. 26-36
|
artikel
|
| 8 |
Few evaluative studies exist examining rapid review methodology across stages of conduct: a systematic scoping review
|
Hamel, Candyce
|
|
|
126 |
C |
p. 131-140
|
artikel
|
| 9 |
Health items with a novel patient-centered approach provided information for preference-based transplant outcome measure
|
Shahabeddin Parizi, Ahmad
|
|
|
126 |
C |
p. 93-105
|
artikel
|
| 10 |
How personalized are benefit and harm results of randomized trials? A systematic review
|
Yu, Alice
|
|
|
126 |
C |
p. 17-25
|
artikel
|
| 11 |
How subgroup analyses can miss the trees for the forest plots: A simulation study
|
Webster-Clark, Michael
|
|
|
126 |
C |
p. 65-70
|
artikel
|
| 12 |
Impact of tumor heterogeneity and tissue sampling for genetic mutation testing: a systematic review and post hoc analysis
|
Swift, Stephanie L.
|
|
|
126 |
C |
p. 45-55
|
artikel
|
| 13 |
Is it always possible to complete a systematic review in 2 weeks? Further thoughts and considerations
|
Yan, Kevin
|
|
|
126 |
C |
p. 162-163
|
artikel
|
| 14 |
It's always about numerators and denominators (N/D)
|
Knottnerus, J. André
|
|
|
126 |
C |
p. A7-A9
|
artikel
|
| 15 |
New outcome-specific comorbidity scores excelled in predicting in-hospital mortality and healthcare charges in administrative databases
|
Shin, Jung-ho
|
|
|
126 |
C |
p. 141-153
|
artikel
|
| 16 |
No one will be left behind: when the prioritization of systematic reviews registry widens research inequalities between countries
|
Hernández-Vásquez, Akram
|
|
|
126 |
C |
p. 160
|
artikel
|
| 17 |
Not all systematic reviews can be completed in 2 weeks—But many can be (and should be)
|
Clark, Justin
|
|
|
126 |
C |
p. 163
|
artikel
|
| 18 |
Open synthesis and the coronavirus pandemic in 2020
|
Haddaway, Neal R.
|
|
|
126 |
C |
p. 184-191
|
artikel
|
| 19 |
PRECIS-2 for retrospective assessment of RCTs in systematic reviews
|
Zwarenstein, Merrick
|
|
|
126 |
C |
p. 202-206
|
artikel
|
| 20 |
Rapid review methods more challenging during COVID-19: commentary with a focus on 8 knowledge synthesis steps
|
Tricco, Andrea C.
|
|
|
126 |
C |
p. 177-183
|
artikel
|
| 21 |
Response to Akram Hernández-Vásquez and Diego Azanedo's “No one will be left behind: when the prioritization of systematic reviews registry widens research inequalities between countries”
|
Walker, Ruth
|
|
|
126 |
C |
p. 161-162
|
artikel
|
| 22 |
ROC curves for clinical prediction models part 1. ROC plots showed no added value above the AUC when evaluating the performance of clinical prediction models
|
Verbakel, Jan Y.
|
|
|
126 |
C |
p. 207-216
|
artikel
|
| 23 |
ROC curves for clinical prediction models part 4. Selection of the risk threshold—once chosen, always the same?
|
Janssens, A. Cecile J.W.
|
|
|
126 |
C |
p. 224-225
|
artikel
|
| 24 |
ROC curves for clinical prediction models part 3. The ROC plot: a picture that needs a 1000 words
|
Van Calster, Ben
|
|
|
126 |
C |
p. 220-223
|
artikel
|
| 25 |
ROC curves for clinical prediction models part 2. The ROC plot: the picture that could be worth a 1000 words
|
Janssens, A. Cecile J.W.
|
|
|
126 |
C |
p. 217-219
|
artikel
|
| 26 |
Scientific publications in cancer: in Latin America, strong scientific networks increase productivity (the TENJIN study)
|
Ruiz-Patiño, Alejandro
|
|
|
126 |
C |
p. 1-8
|
artikel
|
| 27 |
Systematic scoping review identifies heterogeneity in outcomes measured in adolescent depression clinical trials
|
Mew, Emma J.
|
|
|
126 |
C |
p. 71-79
|
artikel
|
| 28 |
Table of Contents
|
|
|
|
126 |
C |
p. A3-A6
|
artikel
|
| 29 |
Testing COVID-19 tests faces methodological challenges
|
Bossuyt, Patrick M.
|
|
|
126 |
C |
p. 172-176
|
artikel
|
| 30 |
The design can limit PRECIS-2 retrospective assessment of the clinical trial explanatory/pragmatic features
|
Dal-Ré, Rafael
|
|
|
126 |
C |
p. 193-201
|
artikel
|
| 31 |
The Emtree term “diagnostic test accuracy study” retrieved less than half of the diagnostic accuracy studies in Embase
|
Gurung, Pema
|
|
|
126 |
C |
p. 116-121
|
artikel
|
| 32 |
The importance of publishing non-COVID-19 research during COVID-19
|
Chaitoff, Alexander
|
|
|
126 |
C |
p. 192
|
artikel
|
| 33 |
The 25-item Dizziness Handicap Inventory was shortened for use in general practice by 60 percent
|
van Vugt, Vincent A.
|
|
|
126 |
C |
p. 56-64
|
artikel
|
| 34 |
The quality of evidence for medical interventions does not improve or worsen: a metaepidemiological study of Cochrane reviews
|
Howick, Jeremy
|
|
|
126 |
C |
p. 154-159
|
artikel
|
| 35 |
The revised Cochrane risk of bias tool for randomized trials (RoB 2) showed low interrater reliability and challenges in its application
|
Minozzi, Silvia
|
|
|
126 |
C |
p. 37-44
|
artikel
|
| 36 |
The UpPriority tool was developed to guide the prioritization of clinical guideline questions for updating
|
Sanabria, Andrea Juliana
|
|
|
126 |
C |
p. 80-92
|
artikel
|
| 37 |
Unknown confounders did not bias the treatment effect when improving balance of known confounders in randomized trials
|
Kuss, Oliver
|
|
|
126 |
C |
p. 9-16
|
artikel
|
Tijdschrift beschrijving